NOVEMBER 2023LIFE SCIENCES REVIEW4CONTENTSCONTENTSNew Product Liability Directive in Europe: Implications for the Pharmaceutical IndustryFrom Complex to Compliance: 3 Keys for Unlocking the Regulatory PathwayXavier Salas, Corporate Legal & Compliance Manager, NeuraxpharmNicholas Smalley, Vice President of Regulatory Affairs, Kindeva Drug Delivery IN MY OPINION08LAST WORD3012C O V E R S T OR YUNLOCKING THE POTENTIAL OF NEXT-GENERATION SEQUENCINGPETER RENÉ HESSE, VICE PRESIDENT HEAD OF GENOMICS BUSINESS, QIAGEN [NYSE:QGEN]
< Page 3 | Page 5 >